Who owns ZENTALIS PHARMACEUTICALS INC COM?
- Ticker: ZNTL
- CUSIP Number: 98943l107
Tip: Access positions for across all investors
Analyze quarterly positions in Zentalis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zentalis Pharmaceuticals stock
Who bought or sold ZENTALIS PHARMACEUTICALS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 12M | $182M | 0% | Mar 2024 |
|
| FMR | 11M | $168M | 12% | Mar 2024 |
|
| BlackRock | 4.6M | $73M | 6% | Mar 2024 |
|
| Vanguard Group | 4.4M | $69M | -18% | Mar 2024 |
|
| Citadel Advisors | 3.9M | $61M | 4% | Mar 2024 |
|
| T. Rowe Price Associates | 3.5M | $55M | 20% | Mar 2024 |
|
| T. Rowe Price Investment Management | 3.3M | $52M | 68% | Mar 2024 |
|
| Federated Investors | 2.2M | $33M | 11% | Dec 2023 |
|
| Decheng Capital | 2.1M | $32M | 100% | Dec 2023 |
|
| MPM Oncology Impact Management | 1.5M | $24M | 100% | Mar 2024 |
|
| Woodline Partners | 1.4M | $23M | 44% | Mar 2024 |
|
| Geode Capital Management | 1.3M | $21M | 10% | Mar 2024 |
|
| Verition Fund Management | 1.2M | $18M | 115% | Mar 2024 |
|
| Morgan Stanley | 1.0M | $16M | 90% | Mar 2024 |
|
| PRIMECAP Management Company | 1.0M | $16M | -1% | Dec 2023 |
|
| Paradigm Biocapital Advisors | 945k | $15M | 136% | Mar 2024 |
|
| Dimensional Fund Advisors | 724k | $11M | 0% | Mar 2024 |
|
| Northern Trust | 524k | $8.3M | -3% | Mar 2024 |
|
| 5AM Venture Management | 490k | $7.7M | 0% | Mar 2024 |
|
| Bank of America Corporation | 476k | $7.5M | -34% | Mar 2024 |
|
| Charles Schwab Investment Management | 456k | $7.2M | 2% | Mar 2024 |
|
| Boxer Capital | 450k | $7.1M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 332k | $5.2M | 13% | Mar 2024 |
|
| Rafferty Asset Management | 298k | $4.7M | 48% | Mar 2024 |
|
| Bank of New York Mellon | 290k | $4.6M | 0% | Mar 2024 |
|
| UBS Group | 268k | $4.2M | 243414% | Mar 2024 |
|
| TD Asset Management | 259k | $4.1M | 36% | Mar 2024 |
|
| Citigroup | 257k | $4.1M | 76% | Mar 2024 |
|
| Millennium Management | 246k | $3.9M | 702% | Mar 2024 |
|
| Two Sigma Investments | 245k | $3.9M | 100% | Mar 2024 |
|
| Opaleye Management | 200k | $3.2M | 100% | Mar 2024 |
|
| Mayo Clinic | 187k | $2.9M | 0% | Mar 2024 |
|
| Ing Investment Management | 145k | $2.3M | 31% | Mar 2024 |
|
| PDT Partners | 131k | $2.1M | 100% | Mar 2024 |
|
| Nuveen Asset Management | 130k | $2.1M | 2% | Mar 2024 |
|
| Jane Street | 124k | $2.0M | 170% | Mar 2024 |
|
| Hrt Financial | 114k | $1.8M | 100% | Mar 2024 |
|
| Two Sigma Advisers | 101k | $1.6M | 100% | Mar 2024 |
|
| Swiss National Bank | 97k | $1.5M | 0% | Mar 2024 |
|
| Marshall Wace | 89k | $1.4M | 0% | Mar 2024 |
|
| Rhumbline Advisers | 83k | $1.3M | 2% | Mar 2024 |
|
| Values First Advisors | 71k | $1.1M | 48% | Mar 2024 |
|
| Susquehanna International | 70k | $1.1M | -38% | Mar 2024 |
|
| Wellington Management Company | 69k | $1.0M | -96% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 68k | $1.1M | 7% | Mar 2024 |
|
| Barclays | 66k | $1.0M | -70% | Mar 2024 |
|
| Commonwealth Equity Services | 61k | $960k | 12% | Mar 2024 |
|
| Balyasny Asset Management | 59k | $934k | 422% | Mar 2024 |
|
| Jpmorgan Chase & Co | 59k | $924k | -37% | Mar 2024 |
|
| Alliancebernstein | 58k | $874k | 0% | Dec 2023 |
|
| Legal & General Group | 57k | $895k | 2% | Mar 2024 |
|
| California State Teachers Retirement System | 50k | $794k | -11% | Mar 2024 |
|
| Credit Suisse | 48k | $763k | -1% | Mar 2024 |
|
| ALPS Advisors | 48k | $726k | -8% | Dec 2023 |
|
| ProFund Advisors | 46k | $731k | 36% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 43k | $680k | 100% | Mar 2024 |
|
| Thomas Stevens, CFA" | 39k | $606k | 100% | Mar 2024 |
|
| Tudor Investment Corporation | 35k | $556k | 100% | Mar 2024 |
|
| Algert Coldiron Investors | 33k | $505k | 100% | Dec 2023 |
|
| State of Wisconsin Investment Board | 33k | $519k | -11% | Mar 2024 |
|
| Pennant Investors | 32k | $511k | 100% | Mar 2024 |
|
| Mirae Asset Global Investments | 32k | $535k | -22% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 31k | $486k | -28% | Mar 2024 |
|
| MetLife Investment Advisors | 31k | $465k | 0% | Dec 2023 |
|
| Regency Capital Management | 30k | $465k | -1% | Mar 2024 |
|
| American International | 29k | $439k | 0% | Dec 2023 |
|
| Thrivent Financial for Lutherans | 29k | $453k | -5% | Mar 2024 |
|
| Engineers Gate Manager | 26k | $404k | 13% | Mar 2024 |
|
| New York Life Investment Management | 25k | $399k | 100% | Mar 2024 |
|
| Squarepoint Ops | 23k | $364k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 22k | $345k | 0% | Mar 2024 |
|
| Henderson Group | 22k | $338k | 0% | Mar 2024 |
|
| Exchange Traded Concepts | 20k | $318k | 237% | Mar 2024 |
|
| Wells Fargo & Company | 20k | $317k | 9% | Mar 2024 |
|
| Corton Capital | 20k | $312k | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 20k | $307k | 100% | Mar 2024 |
|
| Prospera Financial Services | 18k | $277k | 100% | Dec 2023 |
|
| Entropy Technologies | 18k | $277k | -57% | Mar 2024 |
|
| Florida State Board of Administration | 16k | $274k | -4% | Mar 2024 |
|
| Zurcher Kantonalbank | 16k | $246k | 100% | Mar 2024 |
|
| ProShare Advisors | 15k | $243k | 27% | Mar 2024 |
|
| Principal Financial Group | 15k | $243k | 3% | Mar 2024 |
|
| Heritage Wealth Management | 15k | $236k | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 14k | $225k | 100% | Mar 2024 |
|
| E Fund Management | 14k | $222k | -27% | Mar 2024 |
|
| China Universal Asset Management | 14k | $215k | 67% | Mar 2024 |
|
| Arizona State Retirement System | 14k | $215k | -1% | Mar 2024 |
|
| Brevan Howard Capital Management | 14k | $214k | 100% | Mar 2024 |
|
| Handelsbanken Fonder AB | 14k | $213k | 0% | Mar 2024 |
|
| Carson Advisory | 13k | $201k | 100% | Mar 2024 |
|
| CornerCap Investment Counsel | 13k | $198k | 100% | Mar 2024 |
|
| Raymond James & Associates | 12k | $191k | 100% | Mar 2024 |
|
| Kennedy Capital Management | 12k | $189k | 100% | Mar 2024 |
|
| Creative Planning | 12k | $183k | 5% | Mar 2024 |
|
| OneAscent Financial Services | 11k | $180k | 11% | Mar 2024 |
|
| Teacher Retirement System Of Texas | 11k | $174k | -3% | Mar 2024 |
|
| 49 Wealth Management | 11k | $172k | 100% | Mar 2024 |
|
| XTX Topco | 11k | $167k | -44% | Mar 2024 |
|
| GSA Capital Partners | 11k | $167k | 100% | Mar 2024 |
|
| Point72 | 9.0k | $143k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 5.8k | $92k | 0% | Mar 2024 |
|
| Virtus ETF Advisers | 5.8k | $91k | -6% | Mar 2024 |
|
| Point72 Asia | 3.4k | $54k | 100% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 3.4k | $51k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 2.9k | $46k | -84% | Mar 2024 |
|
| Amalgamated Bank | 2.0k | $31k | -76% | Mar 2024 |
|
| Pacer Advisors | 1.4k | $22k | 100% | Mar 2024 |
|
| Quest Partners | 1.4k | $21k | -45% | Mar 2024 |
|
| EverSource Wealth Advisors | 1.0k | $16k | 0% | Mar 2024 |
|
| NISA Investment Advisors | 686.00 | $11k | 21% | Mar 2024 |
|
| Us Bancorp | 650.00 | $10k | -1% | Mar 2024 |
|
| Cutler | 600.00 | $9.0k | -33% | Mar 2024 |
|
| Advisor Group Holdings | 331.00 | $5.2k | -49% | Mar 2024 |
|
| Daiwa Securities Group | 212.00 | $3.0k | 0% | Mar 2024 |
|
| HighMark Wealth Management | 130.00 | $2.0k | 0% | Mar 2024 |
|
| Lindbrook Capital | 119.00 | $1.9k | 100% | Mar 2024 |
|
| Proequities | 100.00 | $1.6M | 0% | Mar 2024 |
|
| Tower Research Capital | 64.00 | $1.0k | -94% | Mar 2024 |
|
| Signature | 47.00 | $741.002000 | 57% | Mar 2024 |
|
| Versant Capital Management | 46.00 | $725.001400 | 100% | Mar 2024 |
|
| CWM | 39.00 | $999.999000 | 100% | Mar 2024 |
|
| GAMMA Investing | 26.00 | $409.999200 | 37% | Mar 2024 |
|
| Riggs Asset Managment | 23.00 | $362.999800 | 100% | Mar 2024 |
|
| FinTrust Capital Advisors | 17.00 | $263.000200 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 11.00 | $173.000300 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 10.00 | $161.000000 | 0% | Mar 2024 |
|
| Covestor | 7.00 | $0 | 75% | Mar 2024 |
|
Who sold out of Zentalis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sofinnova Ventures | Sep 2023 | 1.2M | $24M |
| Logos Global Management | Dec 2023 | 500k | $7.6M |
| Caption Management | Dec 2023 | 476k | $7.2M |
| Integral Health Asset Management | Sep 2023 | 450k | $9.0M |
| Adage Capital Partners GP | Sep 2023 | 302k | $6.1M |
| Ensign Peak Advisors | Sep 2023 | 195k | $3.9M |
| Voloridge Investment Management | Dec 2023 | 176k | $2.7M |
| Ameriprise Financial | Sep 2023 | 166k | $3.3M |
| Norges Bank Investment Management | Dec 2023 | 164k | $2.5M |
| SG Americas Securities | Dec 2023 | 153k | $2.3M |
| Qube Research & Technologies | Sep 2023 | 141k | $2.8M |
| Healthcare Of Ontario Pension Plan Trust Fund | Sep 2023 | 47k | $943k |
| Standard Life Aberdeen | Dec 2023 | 40k | $608k |
| Simplex Trading | Dec 2023 | 31k | $470k |
| HighTower Advisors | Dec 2023 | 30k | $453k |
| Trexquant Investment | Sep 2023 | 25k | $492k |
| Allianz Asset Management | Sep 2023 | 19k | $377k |
| Virtu Financial | Sep 2023 | 16k | $325k |
| Springbok Capital Management | Sep 2023 | 10k | $204k |
| KBC Group NV | Sep 2023 | 904.00 | $18k |
| Brian McDonald | Sep 2023 | 143.00 | $2.9k |
| Arlington Trust | Dec 2023 | 70.00 | $1.1k |